Immune-Mediated Adverse Effects of Checkpoint Inhibitors: A Clinical Experience
By: Jan Juřica, Roman Goněc, Adela Bártová and Jana Gregorová
References
- Khan S, Gerber DE. Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review. Semin Cancer Biol. 2020;64,93–101.
- Wang PF, Chen Y, Song SY et al. Immune-related adverse events associated with anti-PD-1/PD-L1 treatment for malignancies: A meta-analysis. Front Pharmacol. 2017;8,730.
DOI: https://doi.org/10.2478/afpuc-2022-0006 | Journal eISSN: 2453-6725
Language: English
Page range: 84 - 86
Submitted on: Apr 25, 2022
Accepted on: May 10, 2022
Published on: Jun 18, 2022
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Related subjects:
© 2022 Jan Juřica, Roman Goněc, Adela Bártová, Jana Gregorová, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.